Page 40 - Simulations Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. Simulations Plus Enters Agreement with Distributor in China February 2, 2021 GMT LANCASTER, Calif.--(BUSINESS WIRE)--Feb 2, 2021-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a distribution agreement with Mosim, one of China’s leading biopharmaceutical services companies, to distribute MonolixSuite™, the Lixoft division’s phar...

The recent report on “Global Molecular Modelling Market Report by Key Players, Types, Applications, Market Size, Market Share, Regions and  Forecast to 2027” offered by Data bridge market research covers various industry dynamics and tendencies that helps in the market growth.Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Molecular Modelling Market”. The research report also offers the latest industry data, future trends, products and end-users revenue growth and effectiveness, which is al...

25 The recent report on “Global Molecular Modelling Market Report by Key Players, Types, Applications, Market Size, Market Share, Regions and  Forecast to 2027” offered by Data bridge market research covers various industry dynamics and tendencies that helps in the market growth.Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Molecular Modelling Market”. The research report also offers the latest industry data, future trends, products and end-users revenue growth and effectiveness, which i...

Press release content from Business Wire. The AP news staff was not involved in its creation. Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics January 14, 2021 GMT LANCASTER, Calif.--(BUSINESS WIRE)--Jan 14, 2021-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen division has awarded a grant to the Department of Pharmacology and Therapeutics at Makerere University in Kampala, Uganda, the country...

First quarter revenue of $10.7 million, reflecting 14% year-over-year growthBoard of Directors announces quarterly dividend of $0.06 per shareLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemic...